v3.26.1
WARRANTS
3 Months Ended
Mar. 31, 2026
Warrants  
WARRANTS

Note 12     WARRANTS

 

IPO Warrants

 

In connection with the Company’s initial public offering, the Company issued warrants to purchase shares of its Common Stock (the “IPO Warrants”). The IPO Warrants contain exercise price reset provisions whereby the exercise price may be adjusted based on the VWAP of the Common Stock following issuance. In addition, the Company may, subject to holder consent, reduce the exercise price at the discretion of the Board of Directors. The IPO Warrants also provide the Company with redemption rights at a price equal to a multiple of the exercise price upon the satisfaction of certain market-based conditions. Due to the presence of exercise price reset features, discretionary repricing provisions and non-nominal redemption terms, the IPO Warrants do not meet the criteria for equity classification. Accordingly, the IPO Warrants are classified as warrant liabilities and are recorded at fair value at each reporting date, with changes in fair value recognized in earnings.

 

The IPO Warrants are classified as Level 3 within the fair value hierarchy because they are not traded in an active market and their valuation relies on significant unobservable inputs. The fair value of the IPO Warrants is estimated using the Black-Scholes option pricing model, incorporating assumptions regarding the fair value of the Company’s common stock, expected term, expected volatility, risk-free interest rate, dividend yield, and adjustments for exercise price reset and redemption features. The expected term equals the remaining contractual term, as the IPO Warrants are fully vested and exercisable. Expected volatility is based on the historical volatility of a group of comparable publicly traded companies over a period consistent with the expected term. The risk-free interest rate is based on U.S. Treasury yields with maturities consistent with the expected term. The dividend yield is assumed to be zero, as the Company has not historically paid dividends and does not expect to pay dividends for the foreseeable future. Changes in key assumptions could materially affect the estimated fair value of the IPO Warrants.

          
   March 31,
2026
  December 31,
2025
Exercise price   1.925    1.925 
Risk free rate   3.72%    3.47% 
Dividend yield   0%    0% 
Expected term (year)   1.40    1.65 
Expected volatility   35.68%    36.67% 

 

The following is a reconciliation of the beginning and ending balances of warrants liability measured at fair value on a recurring basis using Level 3 inputs:

          
   March 31,
2026
  December 31,
2025
    $     $  
Fair value at the beginning of period   25,859    76,847 
Fair value change of warrants included in earnings   (25,859)   (50,988)
Fair value at the end of period       25,859 

 

The following is a summary of the IPO warrant activity:

         
  

Number of

Warrants

 

Average

Exercise Price

 

Weighted

Average

Remaining

Contractual

Term in

Years

          
Outstanding and exercisable at January 1, 2025  1,980,831    1.93    1.62 
Exercised            
Granted             
Expired             
Outstanding and exercisable at March 31, 2026  1,980,831    1.93    1.37 

 

Class A and Class B warrants

 

The Company has issued Class A and Class B warrants to employees and other service providers as part of its equity compensation arrangements. The Class A and Class B warrants are exercisable into a fixed number of shares of the Company’s common stock at fixed exercise prices and are classified as equity.

 

The Company estimated the grant-date fair value of warrants issued to service providers using the Black-Scholes option pricing model. The valuation model requires assumptions related to the fair value of the Common Stock on the grant date, expected term, expected volatility, risk-free interest rate, and dividend yield. These warrants are recognized as stock-based compensation expense over the requisite service period and are not subsequently remeasured after the grant date.

 

The expected term of the warrants was estimated based on the contractual term of the warrants, as the warrants were fully vested and exercisable upon grant and no vesting period applies. Expected volatility was estimated using the historical volatility of comparable publicly traded companies over a period consistent with the expected term of the warrants. The risk-free interest rate was based on the U.S. Treasury yield in effect at the grant date with a maturity corresponding to the expected term of the warrants. The Company has not historically paid dividends and does not expect to pay dividends in the foreseeable future; therefore, the dividend yield was assumed to be zero.

 

   
   March 31, 2026
Exercise price  $1.50 
Risk free rate   3.72% 
Dividend yield   0% 
Expected term (year)   5 
Expected volatility   40.33% 

 

The following is a summary of the Class A and Class B warrant activity:

              
  

Number of

Warrants

 

Average

Exercise Price

 

Weighted

Average

Remaining

Contractual

Term in

Years

          
Outstanding and exercisable at January 1, 2025  666,667   $1.04    1.39 
Exercised             
Granted             
Expired             
Outstanding and exercisable at March 31, 2026  666,667   $1.04    1.14